Andrew John Matthew Clark
Voorzitter bij vasopharm GmbH
Vermogen: 235 507 $ op 31-05-2024
Profiel
Andrew John Matthew Clark was the founder of Reabourne Ltd., which was founded in 1995 where he held the title of Portfolio Manager from 1995 to 2003.
He is currently the Chairman-Supervisory Board at vasopharm GmbH.
Dr. Clark's former positions include Director at Liminal BioSciences, Inc., Senior Independent Non-Executive Director at Lifeline Scientific, Inc., and Director at Hologic Ltd.
Dr. Clark received a doctorate degree from the University of St. Andrews.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-05-2023 | 3 066 502 ( 1.08% ) | 235 507 $ | 31-05-2024 |
Actieve functies van Andrew John Matthew Clark
| Bedrijven | Functie | Begin |
|---|---|---|
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Voorzitter | - |
Eerdere bekende functies van Andrew John Matthew Clark
| Bedrijven | Functie | Einde |
|---|---|---|
| Reabourne Ltd. | Oprichter | 01-01-2003 |
| LIMINAL BIOSCIENCES INC. | Directeur/Bestuurslid | - |
| LIFELINE SCIENTIFIC, INC | Directeur/Bestuurslid | - |
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Directeur/Bestuurslid | - |
Opleiding van Andrew John Matthew Clark
| University of St. Andrews | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LIMINAL BIOSCIENCES INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Lifeline Scientific, Inc.
 Lifeline Scientific, Inc. Medical SpecialtiesHealth Technology Lifeline Scientific, Inc. engages in developing and marketing medical products and services. Its business units include organ recovery systems and tissue testing technologies. The company was founded by David Kravitz on October 1, 1998 and is headquartered in Itasca, IL. | Health Technology |
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
| Reabourne Ltd. |
